Arbutus Biopharma Corp (ABUS)
Pharmaceutical Preparations
Latest Price
$4.34
TTM P/E
5.23
Normalized P/E
--
Div Yield
--
Book Value
1.34
P/B Ratio
3.23
Institutional Ownership
68.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MORGAN STANLEY | 25.89M | $116.0M | 13.15% | -811.3K | 2026-03-31 |
| Two Seas Capital LP | 18.56M | $83.0M | 9.42% | +5.97M | 2026-03-31 |
| Whitefort Capital Management, LP | 14.93M | $67.0M | 7.58% | +1.59M | 2026-03-31 |
| BlackRock, Inc. | 12.97M | $58.0M | 6.58% | -85.9K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.69M | $30.0M | 3.40% | -- | 2026-03-31 |
| Rubric Capital Management LP | 6.63M | $29.0M | 3.36% | +5.05M | 2026-03-31 |
| STATE STREET CORP | 6.34M | $28.0M | 3.22% | +434.3K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.77M | $16.0M | 1.92% | +94.5K | 2026-03-31 |
| ADAR1 Capital Management, LLC | 3.13M | $14.0M | 1.59% | -2.28M | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.66M | $11.0M | 1.35% | -1.68M | 2026-03-31 |